PMID- 16962375 OWN - NLM STAT- MEDLINE DCOM- 20070118 LR - 20210102 IS - 1471-4914 (Print) IS - 1471-4914 (Linking) VI - 12 IP - 10 DP - 2006 Oct TI - MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts. PG - 465-72 AB - The evaluation and characterization of epitope-specific human leukocyte antigen (HLA)-restricted memory T-cell reactivity is an important step for the development of preventive vaccines and peptide-based immunotherapies for viral and tumor diseases. The past decade has witnessed the use of HLA-restricted peptides as tools to activate strong immune responses of naive or memory T cells specifically. This has fuelled an active search for methodological approaches focusing on HLA and peptide associations. Here, we outline new perspective on the emerging opportunity of evaluating HLA and peptide restriction by using novel approaches, such as quantitative real-time PCR, that can identify epitope specificities that are potentially useful in clinical settings. FAU - Provenzano, Maurizio AU - Provenzano M AD - Institute for Surgical Research and Hospital Management, University of Basel, 4031 Basel, Switzerland. mprovenzano@uhbs.ch FAU - Panelli, Monica C AU - Panelli MC FAU - Mocellin, Simone AU - Mocellin S FAU - Bracci, Laura AU - Bracci L FAU - Sais, Giovanni AU - Sais G FAU - Stroncek, David F AU - Stroncek DF FAU - Spagnoli, Giulio C AU - Spagnoli GC FAU - Marincola, Francesco M AU - Marincola FM LA - eng PT - Journal Article DEP - 20060907 PL - England TA - Trends Mol Med JT - Trends in molecular medicine JID - 100966035 RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (HLA Antigens) RN - 0 (Peptides) SB - IM MH - Animals MH - Antigen Presentation/immunology MH - *Epitope Mapping MH - Epitopes, T-Lymphocyte/*immunology MH - HLA Antigens/therapeutic use MH - Humans MH - Immunologic Memory MH - *Immunotherapy MH - *Major Histocompatibility Complex MH - Models, Biological MH - Peptides/*immunology MH - Polymerase Chain Reaction MH - Signal Transduction/physiology MH - Substrate Specificity EDAT- 2006/09/12 09:00 MHDA- 2007/01/19 09:00 CRDT- 2006/09/12 09:00 PHST- 2006/04/21 00:00 [received] PHST- 2006/08/04 00:00 [revised] PHST- 2006/08/24 00:00 [accepted] PHST- 2006/09/12 09:00 [pubmed] PHST- 2007/01/19 09:00 [medline] PHST- 2006/09/12 09:00 [entrez] AID - S1471-4914(06)00195-X [pii] AID - 10.1016/j.molmed.2006.08.008 [doi] PST - ppublish SO - Trends Mol Med. 2006 Oct;12(10):465-72. doi: 10.1016/j.molmed.2006.08.008. Epub 2006 Sep 7.